| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10930505 | Cytotherapy | 2015 | 7 Pages |
Abstract
Our results identified BMP/Smad signaling as an essential negative regulator of promyogenic BMSC activity; inhibition of this pathway improved the efficiency of BMSC myogenic differentiation, which suggests that this pathway might serve as a target to regulate BMSC function for better myogenic differentiation during treatment of DMD and degenerative skeletal muscle diseases.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Cao Jiqing, Li Yaqin, Liang Yingyin, Chen Fei, Zhang Huili, Zhu Yuling, Yang Juan, Feng Shanwei, Zhang Cheng,